Therapeutic effects of hybrid liposomes with downregulation of inflammatory cytokine for model mice of rheumatoid arthritis in vivo

Bioorganic and Medicinal Chemistry Letters

Volumn 25, Issue 13, 2015, Pages 2686-2689

  Ichihara, Hideaki ^a   Yamasaki, Shuichi ^a   Hino, Motoki ^a   Ueoka, Ryuichi ^a   Matsumoto, Yoko ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Collagen induced arthritis mouse models; Hybrid liposomes; In vivo; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ETHER DERIVATIVE; HYBRID LIPOSOME 23; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; MACROGOL DERIVATIVE; POLYOXYETHYLENE (23) DODECYLETHER;

ANIMAL MODEL; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DOWN REGULATION; HISTOLOGY; IN VIVO STUDY; JOINT SWELLING; MOUSE; NONHUMAN; RHEUMATOID ARTHRITIS; SYNOVIUM; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CHEMISTRY; DBA MOUSE; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOSOMES; MICE; MICE, INBRED DBA; POLYETHYLENE GLYCOLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930178961     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.04.083     Document Type: Article

References (22)

1. M. Feldmann, F.M. Brennan, and R.N. Maini Cell 85 1996 307
2. D.L. Scott, F. Wolfe, and T.W. Huizinga Lancet 376 2010 1094
3. R. Caporali, M. Caprioli, F. Bobbio-Pallavicini, and C. Montecucco Autoimmun. Rev. 8 2008 139
4. W. Katchamart, J. Trudeau, V. Phumethum, and C. Bombardier Ann. Rheum. Dis. 68 2009 1105
5. A.M. Hopkins, C.E. O'Doherty, D.J. Foster, V. Suppiah, R.N. Upton, L.D. Spargo, L.G. Cleland, S.M. Proudman, and M.D. Wiese J. Clin. Pharm. Ther. 39 2014 555
6. N.M. Janssen, and M.S. Genta Arch. Intern. Med. 160 2000 610
7. E.N. van Roon, T.L. Jansen, N.M. Houtman, P. Spoelstra, and J.R. Brouwers Drug Safety 27 2004 345
8. J. Tebib, X. Mariette, P. Bourgeois, R.M. Flipo, P. Gaudin, X. Le Loët, P. Gineste, L. Guy, C.D. Mansfield, A. Moussy, P. Dubreuil, O. Hermine, and J. Sibilia Arthritis Res. Ther. 11 2009 R95
9. K. Yokota, Y. Akiyama, Y. Asanuma, F. Miyoshi, K. Sato, and T. Mimura Rheumatol. Int. 29 2009 459
10. R. Ueoka, Y. Matsumoto, R.A. Moss, S. Swarup, G. Straus, and Y. Murakami J. Am. Chem. Soc. 107 1985 2185
11. R. Ueoka, Y. Matsumoto, R.A. Moss, S. Swarup, A. Sugii, K. Harada, J. Kikuchi, and Y. Murakami J. Am. Chem. Soc. 110 1988 1588
12. I. Kitamura, M. Kochi, Y. Matsumoto, R. Ueoka, J. Kuratsu, and Y. Ushio Cancer Res. 56 1996 3986
13. Y. Matsumoto, Y. Iwamoto, T. Matsushita, and R. Ueoka Int. J. Cancer 115 2005 377
14. Y. Iwamoto, Y. Matsumoto, and R. Ueoka Int. J. Pharm. 292 2005 231
15. S. Shimoda, H. Ichihara, Y. Matsumoto, and R. Ueoka Int. J. Pharm. 372 2009 162
16. H. Ichihara, M. Hino, M. Umebayashi, Y. Matsumoto, and R. Ueoka Eur. J. Med. Chem. 57 2012 143
17. H. Ichihara, H. Nagami, T. Kiyokawa, Y. Matsumoto, and R. Ueoka Anticancer Res. 28 2008 1187
18. H. Ichihara, M. Hino, T. Makizono, M. Umebayashi, Y. Matsumoto, and R. Ueoka Bioorg. Med. Chem. Lett. 21 2011 207
19. D.B. David, A.L. Kary, and F.R. Edward Nature Protocols 2 2007 1269
20. H. Yoshitomi, N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. Sakihama, K. Hirota, S. Tanaka, T. Nomura, I. Miki, S. Gordon, S. Akira, T. Nakamura, and S. Sakaguchi J. Exp. Med. 201 2005 949
21. Y. Juarranz, C. Abad, C. Martinez, A. Arranz, I. Gutierrez-Canas, F. Rosignoli, R.P. Gomariz, and J. Leceta Arthritis Res. Ther. 7 2005 1034
22. H. Zhenlin, J. Qing, D. Jieping, L. Fang, L. Runhui, S. Lei, Z. Huawu, Z. Junping, and Z. Weidong Arthritis Rheum. 63 2011 949